Oral Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome

PURPOSE: Efficacy and toxicity profile of orally administered clofarabine were evaluated in patients with higher-risk myelodysplastic syndrome (MDS). PATIENTS AND METHODS: Thirty-two patients were treated, of whom 22 had intermediate-2 or high-risk disease (International Prognostic Scoring System)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Faderl, Stefan, Garcia-Manero, Guillermo, Estrov, Zeev, Ravandi, Farhad, Borthakur, Gautam, Cortes, Jorge E., O'Brien, Susan, Gandhi, Varsha, Plunkett, William, Byrd, Anna, Kwari, Monica, Kantarjian, Hagop M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872315/
https://ncbi.nlm.nih.gov/pubmed/20421540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.3509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados